January 2, 2017 / 6:27 AM / 7 months ago

BRIEF-Natco Pharma launches Velpanat in Nepal

1 Min Read

Jan 2 (Reuters) - Natco Pharma Ltd

* Natco Pharma Ltd says Natco launches Velpanat in Nepal

* Natco Pharma Ltd says Epclusa is used for the treatment of patients with HCV Genotype 2 and 3 Source text - (bit.ly/2hIPKwp) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below